Tech Company Financing Transactions

Antios Therapeutics Funding Round

On 11/6/2021, Antios Therapeutics announced $75 million in Series B funding from Epiq Capital, GordonMD Global Investments and Adage Capital Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

575 Pharr Rd. North East 12260
Atlanta, GA 30355
USA

Phone

Undisclosed

Website

www.antiostherapeutics.com

Email Address

[email protected]

Overview

Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gregory Mayes

        

Chief Financial Officer

Tamra Adams

        

Chief Medical Officer

Douglas Mayers

        

Browse more venture capital transactions:

Prev: 11/6/2021: Medallion venture capital transaction
Next: 11/6/2021: Yellowbrick Data venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary